Blood Component Therapy

Pediatric Clinics of North America

Volumn 55, Issue 2, 2008, Pages 421-445

  Fasano, Ross ^a,b   Luban, Naomi L C ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; FRESH FROZEN PLASMA; GLUCOSE; HLA ANTIBODY; PHOSPHATE;

ALLERGIC REACTION; ALLOIMMUNIZATION; APHERESIS; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FEVER; GAMMA RADIATION; GRANULOCYTE TRANSFUSION; HEMOGLOBINOPATHY; HUMAN; REVIEW; THALASSEMIA; THROMBOCYTE TRANSFUSION; TRANSFUSION RELATED ACUTE LUNG INJURY;

ANTICOAGULANTS; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD SPECIMEN COLLECTION; CHILD; CHILD, PRESCHOOL; GAMMA RAYS; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE REDUCTION PROCEDURES;

EID: 41149128358     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.01.006     Document Type: Review

References (57)

1. Luban N.L. Basics of transfusion medicine. In: Furman B., and Zimmerman J.J. (Eds). Pediatric critical care. 3rd edition (2006), Mosby, Philadelphia 1185-1198
2. Luban N.L., Strauss R.G., and Hume H.A. Commentary on the safety of red cells preserved in extended storage media for neonatal transfusions. Transfusion 31 (1991) 229-235
3. Strauss R.G., Burneister L.F., Johnson K., et al. Feasibility and safety of AS-3 red blood cells for neonatal transfusions. J Pediatr 136 (2000) 215-219
4. Jain R., and Jarosz C. Safety and efficacy of AS-1 red blood cell use in neonates. Transfus Apher Sci 24 2 (2001) 111-115
5. In: Price T.H. (Ed). Standards for blood banks and transfusion services. 25th edition (2008), American Association of Blood Banks, Bethesda (MD)
6. Yazer M.H., Podlosky L., Clarke G., et al. The effect of prestorage leukoreduction on the rates of febrile nonhemolytic transfusion reactions to PC and RBC. Transfusion 44 (2004) 10-15
7. Paglino J.C., Pomper G.J., Fisch G., et al. Reduction of febrile but not allergic reactions to red cells and platelets following conversion to universal prestorage leukoreduction. Transfusion 44 (2004) 16-24
8. King T.E., Tanz W., Shirey S., et al. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to red cells. Transfusion 44 (2004) 25-29
9. Technical manual of the American Association of Blood Banks. 14th edition (2003), American Association of Blood Banks, Bethesda (MD)
10. Luban N.L., and Wong E.C. Hazards of transfusion. In: Arceci R.J., Hann I.M., and Smith O.P. (Eds). Pediatric hematology. 3rd edition (2006), Wiley Blackwell, New York 724-744
11. Bowden R.A., Slichter S.J., Sayers M., et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 86 (1995) 3598-3603
12. Nichols W.G., Price T.H., Gooley T., et al. Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. Blood 101 (2003) 4195-4220
13. Narvios A.B., de Lima M., Shah H., et al. Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients. Bone Marrow Transpl 35 (2005) 499-501
14. Special products. In: Roseff S.D. (Ed). Pediatric transfusion: a physician's handbook. 2nd edition (2006), American Association of Blood Banks, Bethesda (MD) 179-194
15. Strauss R.G. Data-driven blood banking practices for neonatal RBC transfusions. Transfusion 40 12 (2000) 1528-1540
16. Pelsynski M.M., Moroff G., Luban N.L., et al. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 83 6 (1994) 1683-1689
17. Davey R.J., McCoy N.C., Yu M., et al. The effect of prestorage irradiation on postransfusion red cell survival. Transfusion 32 6 (1992) 525-528
18. Blood components. In: Roseff S.D. (Ed). Pediatric transfusion: a physician's handbook. 2nd edition (2006), American Association of Blood Banks, Bethesda (MD) 1-52
19. Weiskopf R.B., Schnapp S., Rouine-Rapp K., et al. Extracellular potassium concentration in red blood cell suspensions after irradiation and washing. Transfusion 45 (2005) 1295-1301
20. Roseff S.D., Luban N.L., and Manno C.S. Guidelines for assessing appropriateness of pediatric transfusion. Transfusion 42 (2002) 1398-1413
21. Robitaille N., and Hume H.A. Blood components and fractionated plasma products: preparations, indications, and administration. In: Arceci R.J., Hann I.M., and Smith O.P. (Eds). Pediatric hematology. 3rd edition (2006), Wiley Blackwell, New York 693-706
22. Vichinsky E.P., Haberkern C.M., Neumayer L., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 333 (1995) 206-213
23. Scotborn D.J., Price C., Schwartz D., et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 140 (2002) 348-354
24. Adams R.J., McKie V.C., Hsu L., et al. Prevention of first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonagraphy. N Engl J Med 339 (1998) 5-11
25. Adams R.J., and Brambilla D. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med 353 (2005) 2769-2778
26. Smith-Whitley K. Alloimmunization in patients with sickle cell disease. In: Manno C.S. (Ed). Pediatric transfusion therapy (2002), AABB Press, Bethesda (MD) 249-282
27. Vichinsky E.P., Luban N.C., Wright E., et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion 41 (2001) 1086-1092
28. Alloimmune cytopenias. In: Roseff S.D. (Ed). Pediatric transfusion: a physician's handbook. 2nd edition (2006), American Association of Blood Banks, Bethesda (MD) 53-97
29. British Committee for Standards in Hematology, Blood Transfusion Task Force. Transfusion guidelines for neonates and older children. Br J Haematol 124 (2004) 433-453
30. Kirpalani H., Whyte R.K., Anderson C., et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 149 (2006) 301-307
31. Bell E.F., Strauss R.G., Widness J.A., et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. J Pediatr 115 (2005) 1685-1691
32. Cid J., and Lozano M. Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Transfusion 45 (2005) 453
33. In: Klein H.G., and Anstee D.J. (Eds). Mollison's blood transfusion in clinical medicine. 11th edition (2005), Blackwell 187-191
34. Molnar R., Johnson R., Sweat L.T., et al. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion 42 (2002) 177-182
35. Gil-Fernandez J.J., Alegre A., FernandezVillalta M.J., et al. Clinical results of a stringent policy on prophylactic platelet transfusion: Non-randomized comparative analysis of 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant 18 (1996) 931-935
36. Heckman K.D., Weiner G.J., and Davis C.S. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000 microL versus 20,000 microL. J Clin Oncol 15 (1997) 1143-1149
37. Wandt H., Frank M., Ehninger G., et al. Safety and cost effectiveness of 10 x 109/L trigger for prophylactic platelet transfusion compared with the traditional 20 x 109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91 (1998) 3601-3606
38. Murray N.A., Horwarth L.J., McCloy M.P., et al. Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 12 (2002) 35-41
39. Vassallo R.R. New paradigms in the management of alloimmune refractoriness to platelet transfusions. Curr Opin Hematol 14 (2007) 655-663
40. Perotta P.L., Pisciotto P.T., and Snyder E.L. Platelets and related products. In: Hillyer C.D., Silberstein L.E., Ness P.M., et al. (Eds). Blood banking and transfusion medicine basic principles and practice. 1st edition (2003), Churchill Livingstone, Philadelphia 181-206
41. Petz L.D., Garatty G., Calhoun L., et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 40 (2000) 1446-1456
42. Delaflor-Weiss E., and Mintz P.D. The evaluation and management of platelet refractoriness and alloimmunization. Transfus Med Rev 14 (2000) 180-196
43. British Committee for Standards in Hematology, Blood Transfusion Task Force. Amendments and corrections to the 'transfusion guidelines for neonates and older children' (BCSH, 2004a); and to the 'Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatent' (BCSH, 2004b). Br J Haematol 136 (2006) 514-516
44. Mathew P. The use of rVIIa in non-hemophilia bleeding conditions in paediatrics. A systematic review. Thromb Haemost 92 (2004) 738-746
45. Mathew P., and Young G. Recombinant factor VIIa in paediatric bleeding disorders-a 2006 review. Haemophilia 12 (2006) 457-472
46. Green D. Complications associated with the treatment of haemophiliacs with inhibitors. Haemophilia 5 Suppl 3 (1999) 11-17
47. Mohan P., and Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 4 (2003) CD003956
48. Bishton M., and Chopra R. The role of granulocyte transfusions in neutropenic patients. Br J Haematol 127 (2004) 501-508
49. Vamvakas E.C., and Pineda A.A. Determinants of the efficacy of prophylactic granulocyte transfusions: a meta-analysis. J Clin Apheresis 12 (1997) 74-81
50. Sanders R.P., Maddirala S.D., Geiger T.L., et al. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children. Br J Haematol 130 (2005) 781-787
51. Davenport R.D. Hemolytic transfusion reactions. In: Popovsky M.A. (Ed). Transfusion reactions. 3rd edition (2007) 1-56
52. Kopko P.M., and Popovsky M.A. Transfusion related acute lung injury. In: Popovsky M.A. (Ed). Transfusion reactions. 3rd edition (2007) 207-228
53. Sanchez R., and Toy P. Transfusion related acute lung injury: a pediatric perspective. Pediatr Blood Cancer 45 (2005) 248-255
54. Silliman C.C., Boshkov L.K., Meddizadehkashi Z., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 101 (2003) 454-462
55. Serious Hazards of Transfusion (SHOT). Annual report. 2006. Manchester, UK: SHOT Scheme, 2006. Available at: http://www.shotuk.org/SHOTREPORT2006.PDF. Accessed March 12, 2008.
56. Eder A.F., Herron R., Strupp A., et al. Transfusion related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47 (2007) 599-607
57. Transfusion-related acute lung injury. Association bulletin #06-07 (2006), AABB, Bethesda (MD). http://www.aabb.org/content/Members_Area/Association_Bulleins/ab06-07.htm Accessed March 12, 2008